F371-0302 Screening compound: 4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3,4,5-trimethoxyphenyl)piperidine-1-carboxamide

F371-0302 Screening compound: 4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3,4,5-trimethoxyphenyl)piperidine-1-carboxamide
F371-0302 Screening compound: 4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3,4,5-trimethoxyphenyl)piperidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F371-0302
4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3,4,5-trimethoxyphenyl)piperidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F371-0302

Molecular Formula

C23H25FN4O5 (C23 H25 FN4 O5)

Compound Name

4-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3,4,5-trimethoxyphenyl)piperidine-1-carboxamide

IUPAC name

4-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]-N-(345-trimethoxyphenyl)piperidine-1-carboxamide

SMILES

COc1cc(NC(N(CC2)CCC2c2nc(-c(cc3)ccc3F)no2)=O)cc(OC)c1OC

InChI

InChI=1S/C23H25FN4O5/c1-30-18-12-17(13-19(31-2)20(18)32-3)25-23(29)28-10-8-15(9-11-28)22-26-21(27-33-22)14-4-6-16(24)7-5-14/h4-7,12-13,15H,8-11H2,1-3H3,(H,25,29)

InChI Key

VYYRVIPOERAXFL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14952182

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

456.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.893

Distribution Coefficient, logD

3.893

Water Solubility, LogSw

-3.98

Polar Surface Area

80.091

Acid Dissociation Constant (pKa)

11.74

Base Dissociation Constant (pKb)

0.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

F371-0302 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with F371-0302 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F371-0302?
Check Price and Availability of F371-0302, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F371-0302 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F371-0302
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F371-0302
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F371-0302 available by request